| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Vitrafy, Australia’s exciting new Bio Tech Company leading the way in innovative new patient orientated outcomes. Vitrafy is revolutionising the delivery of existing and emerging cell-based therapies from the research laboratory to the patient bedside. Giving your loved one the best chance of coming home. Cryopreservation plays a critical role in the biomedical life science industry. Current and emerging cellular therapies require successful cryopreservation of sensitive biological material that to-date, have had notoriously low and inconsistent success rates. Vitrafy have developed new, fully patented, cold chain solutions for the advancement in biomedical cryopreservation. These include a cryopreservation algorithm, freezing apparatus’, thawing apparatus’, tailored racking and packing solutions and a completely integrated software solution that includes data collection, reporting and processing automation. |
| Category: | Hardware & devices, Health & biotech |
| URL: | http://www.vitrafy.com |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2018 |
| Address: | Level 1 47 Sandy Bay Rd Hobart TAS 7000 |
| State: | Tasmania |
| Overseas Operations: | No |
| X: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/vitrafy-life-sciences/ |
| Founders: | |
| Awards won: | |

